The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg

NCT02838810 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: peginterferon alfa
DRUG: Nucleoside analogues

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University

Collaborators

[object Object]
[object Object]
[object Object]